Benzinga | May 6, 2021 04:01PM EDT

Acorda Therapeutics Q1 EPS $(2.46) Beats $(2.54) Estimate, Sales $28.86M Beat $22.15M Estimate

Acorda Therapeutics (NASDAQ:ACOR) reported quarterly losses of $(2.46) per share which beat the analyst consensus estimate of $(2.54) by 3.15 percent. This is a 382.35 percent decrease over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $28.86 million which beat the analyst consensus estimate of $22.15 million by 30.30 percent. This is a 2.72 percent increase over sales of $28.10 million the same period last year.